The eyes may be able to signal neurodevelopmental disorders such as ASD and ADHD, according to new research from Flinders University and the University of South Australia.
Jun 16, 2022
0
53
By age 44, endometriosis affects around one in nine women and people assigned female at birth in Australia.
Jun 6, 2022
0
2
A new study from researchers at Children's Hospital of Philadelphia (CHOP) found that using telemedicine to evaluate patients with rare genetic conditions resulted in a similar rate of proper diagnosis as in-person visits. ...
Jun 1, 2022
0
1
More than two years into the COVID-19 pandemic, most Americans likely share the experience of anxiously awaiting the results of a COVID test, whether a lab-based PCR test administered at a hospital, a "point-of-care" rapid ...
May 24, 2022
0
2
The U.S. Food and Drug Administration granted marketing approval for the Lumipulse G β-Amyloid Ratio (1-42/1-40) test, the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer disease, ...
May 9, 2022
0
5
Researchers at the Stanford Cardiovascular Institute have discovered how viruses like influenza and SARS-CoV-2 as well as their associated vaccines may increase the risk of heart attack, stroke, heart inflammation, and other ...
May 9, 2022
0
258
A potential game-changer in the tuberculosis epidemic was how the tuberculosis community viewed rapid molecular tests for tuberculosis and tuberculosis drug resistance. This was 12 years ago, with the launch of Xpert MTB/RIF, ...
Apr 26, 2022
0
32
The World Health Organization said Friday it "strongly recommended" Pfizer's COVID-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalization.
Apr 21, 2022
0
73
Researchers from the Indiana University (IU) School of Medicine have expanded a screening tool that could lead to more accurate and timely diagnoses—and therefore treatment—of substance use disorder.
Apr 21, 2022
0
67
San Diego startup AltheaDx, which developed a molecular test designed to guide therapy for depression and anxiety based on a patient's genetics, is being acquired for $65 million in stock and cash.
Apr 7, 2022
0
3
